Psychiatry Research
Volume 176, Issue 1 , Pages 30-33 , 30 March 2010

Comorbidity between bipolar disorder and alcohol use disorder: Association of dopamine and serotonin gene polymorphisms

  • Baseer Yasseen

      Affiliations

    • Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada
    • ,
  • James L. Kennedy

      Affiliations

    • Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    • Neuroscience Research Department, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    • ,
  • Laurie A. Zawertailo

      Affiliations

    • Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada
    • Neuroscience Research Department, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    • ,
  • Usoa E. Busto

      Affiliations

    • Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada
    • Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
    • Neuroscience Research Department, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
    • Corresponding Author InformationCorresponding author. 33 Russell Street, Room 1053B Toronto, Ontario, Canada M5S 2S1. Tel.: +1 416 535 8501x6812; fax: +1 416 595 6618.

Received 23 October 2007 ,Revised 4 December 2008 ,Accepted 30 December 2008.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorder. 4th ed.. Washington: American Psychiatric Association; 1994;
  2. Carter TD, Mundo E, Parikh SV, Kennedy JL. Early age at onset as a risk factor for poor outcome of bipolar disorder. Journal of Psychiatric Research. 2003;37(4):297–303
  3. Comings DE, Gade R, Wu S, Chiu C, Dietz G, Muhleman D, et al. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Molecular Psychiatry. 1997;2(1):44–56
  4. Curran GM, Flynn HA, Kirchner J, Booth BM. Depression after alcohol treatment as a risk factor for relapse among male veterans. Journal of Substance Abuse Treatment. 2000;19(3):259–265
  5. Dalton EJ, Cate-Carter TD, Mundo E, Parikh SV, Kennedy JL. Suicide risk in bipolar patients: the role of co-morbid substance use disorders. Bipolar Disorders. 2003;5(1):58–61
  6. Dmitrzak-Weglarz M, Rybakowski JK, Slopien A, Czerski PM, Leszczynska-Rodziewicz A, Kapelski P, et al. Dopamine receptor D1 gene -48A/G polymorphism is associated with bipolar illness but not with schizophrenia in a Polish population. Neuropsychobiology. 2006;53(1):46–50
  7. Elvidge G, Jones I, McCandless F, Asherson P, Owen MJ, Craddock N. Allelic variation of a BalI polymorphism in the DRD3 gene does not influence susceptibility to bipolar disorder: results of analysis and meta-analysis. American Journal of Medical Genetics. 2001;105(4):307–311
  8. Fehr C, Szegedi A, Anghelescu I, Klawe C, Hiemke C, Dahmen N. Sex differences in allelic frequencies of the 5-HT2C Cys23Ser polymorphism in psychiatric patients and healthy volunteers: findings from an association study. Psychiatric Genetics. 2000;10(2):59–65
  9. Fortney JC, Booth BM, Curran GM. Do patients with alcohol dependence use more services? A comparative analysis with other chronic disorders. Alcoholism, Clinical and Experimental Research. 1999;23(1):127–133
  10. Fossey MD, Otto MW, Yates WR, Wisniewski SR, Gyulai L, Allen MH, et al. Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants. American Journal of Addiction. 2006;15(2):138–143
  11. Frye MA, Salloum IM. Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations. Bipolar Disorders. 2006;8(6):677–685
  12. Hayden EP, Nurnberger JI. Molecular genetics of bipolar disorder. Genes, Brain, and Behavior. 2006;5(1):85–95
  13. Jacob T, Waterman B, Heath A, True W, Bucholz KK, Haber R, et al. Genetic and environmental effects on offspring alcoholism: new insights using an offspring-of-twins design. Archives of General Psychiatry. 2003;60(12):1265–1272
  14. Kasper SF. Living with bipolar disorder. Expert Review of Neurotherapeutics. 2004;4(6 Suppl 2):S9–15
  15. Keck PE, McElroy SL, Strakowski SM, West SA, Sax KW, Hawkins JM, et al. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. American Journal of Psychiatry. 1998;155(5):646–652
  16. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry. 1994;51(1):8–19
  17. Kogan JN, Otto MW, Bauer MS, Dennehy EB, Miklowitz DJ, Zhang HW, et al. Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Bipolar Disorders. 2004;6(6):460–469
  18. Kupfer DJ, Frank E, Grochocinski VJ, Cluss PA, Houck PR, Stapf DA. Demographic and clinical characteristics of individuals in a bipolar disorder case registry. Journal of Clinical Psychiatry. 2002;63(2):120–125
  19. Lappalainen J, Long JC, Virkkunen M, Ozaki N, Goldman D, Linnoila M. HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses. Biological Psychiatry. 1999;46(6):821–826
  20. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274(5292):1527–1531
  21. Leszczynska-Rodziewicz A, Hauser J, Dmitrzak-Weglarz M, Skibinka M, Czerski P, Zakrzewska A, et al. Lack of association between polymorphisms of dopamine receptors, type D2, and bipolar affective illness in a Polish population. Medical Science Monitor. 2005;11(6):CR289–295
  22. Lichtermann D, Hranilovic D, Trixler M, Franke P, Jernej B, Delmo CD, et al. Support for allelic association of a polymorphic site in the promoter region of the serotonin transporter gene with risk for alcohol dependence. American Journal of Psychiatry. 2000;157(12):2045–2047
  23. Limosin F, Romo L, Batel P, Ades J, Boni C, Gorwood P. Association between dopamine receptor D3 gene BalI polymorphism and cognitive impulsiveness in alcohol-dependent men. European Psychiatry. 2005;20(3):304–306
  24. McElroy SL, Altshuler LL, Suppes T, Keck PE, Frye MA, Denicoff KD, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. American Journal of Psychiatry. 2001;158(3):420–426
  25. McGuffin P, Katz R. The genetics of depression and manic-depressive disorder. British Journal of Psychiatry. 1989;155:294–304
  26. McQueen MB, Devlin B, Faraone SV, Nimgaonkar VL, Sklar P, Smoller JW, et al. Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. American Journal of Medical Genetics. 2005;77(4):582–595
  27. Muller DJ, de Luca V, Sicard T, King N, Strauss J, Kennedy JL. Brain-derived neurotrophic factor (BDNF) gene and rapid-cycling bipolar disorder: family-based association study. British Journal of Psychiatry. 2006;189:317–323
  28. Munafo MR, Lingford-Hughes AR, Johnstone EC, Walton RT. Association between the serotonin transporter gene and alcohol consumption in social drinkers. American Journal of Medical Genetics B. Neuropsychiatric Genetics. 2005;135B(1):10–14
  29. Mundo E, Zai G, Lee L, Parikh SV, Kennedy JL. The 5HT1Dbeta receptor gene in bipolar disorder: a family-based association study. Neuropsychopharmacology. 2001;25(4):608–613
  30. Murphy GE, Wetzel RD, Robins E, McEvoy L. Multiple risk factors predict suicide in alcoholism. Archives of General Psychiatry. 1992;49(6):459–463
  31. Noble EP. The D2 dopamine receptor gene: a review of association studies in alcoholism and phenotypes. Alcohol. 1998;16(1):33–45
  32. Noble EP. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. European Psychiatry. 2000;15(2):79–89
  33. Nurnberger JI, Foroud T, Flury L, Su J, Meyer ET, Hu K, et al. Evidence for a locus on chromosome 1 that influences vulnerability to alcoholism and affective disorder. American Journal of Psychiatry. 2001;158(5):718–724
  34. Parsian A, Cloninger CR. Serotonergic pathway genes and subtypes of alcoholism: association studies. Psychiatric Genetics. 2001;11(2):89–94
  35. Parsian A, Chakraverty S, Todd RD. Possible association between the dopamine D3 receptor gene and bipolar affective disorder. American Journal of Medical Genetics. 1995;60(3):234–237
  36. Prescott CA, Hewitt JK, Truett KR, Heath AC, Neale MC, Eaves LJ. Genetic and environmental influences on lifetime alcohol-related problems in a volunteer sample of older twins. Journal of Studies on Alcohol. 1994;55(2):184–202
  37. Ranade SS, Mansour H, Wood J, Chowdari KV, Brar LK, Kupfer DJ, et al. Linkage and association between serotonin 2A receptor gene polymorphisms and bipolar I disorder. American Journal of Medical Genetics B. Neuropsychiatric Genetics. 2003;121B(1):28–34
  38. Samochowiec J, Ladehoff M, Pelz J, Smolka M, Schmidt LG, Rommelspacher H, et al. Predominant influence of the 3′-region of dopamine D2 receptor gene (DRD2) on the clinical phenotype in German alcoholics. Pharmacogenetics. 2000;10(5):471–475
  39. Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A, et al. Dopamine D1, D2 and D3 receptor genes in alcohol dependence. Psychiatric Genetics. 1995;5(4):171–176
  40. Segurado R, Detera-Wadleigh SD, Levinson DF, Lewis CM, Gill M, Nurnberger JI, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: bipolar disorder. American Journal of Medical Genetics. 2003;73(1):49–62
  41. Severino G, Congiu D, Serreli C, De Lisa R, Chillotti C, Del Zompo M, et al. A48G polymorphism in the D1 receptor genes associated with bipolar I disorder. American Journal of Medical Genetics B. Neuropsychiatric Genetics. 2005;134B(1):37–38
  42. Suppes T, Leverich GS, Keck PE, Nolen WA, Denicoff KD, Altshuler LL, et al. The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. Journal of Affective Disorders. 2001;67(1–3):45–59
  43. Szczepankiewicz A, Dmitrzak-Weglarz M, Skibinska M, Slopien A, Leszczynska-Rodziewicz A, Czerski P, et al. Study of dopamine receptors genes polymorphisms in bipolar patients with comorbid alcohol abuse. Alcohol and Alcoholism. 2007;42(2):70–74
  44. Thome J, Weijers HG, Wiesbeck GA, Sian J, Nara K, Boning J, et al. Dopamine D3 receptor gene polymorphism and alcohol dependence: relation to personality rating. Psychiatric Genetics. 1999;9(1):17–21
  45. Tyndale RF. Genetics of alcohol and tobacco use in humans. Annals of Medicine. 2003;35(2):94–121
  46. Wodarz N, Bobbe G, Eichhammer P, Weijers HG, Wiesbeck GA, Johann M. The candidate gene approach in alcoholism: are there gender-specific differences?. Archives of Women's Mental Health. 2003;6(4):225–230

☆ The authors of this paper do not hold any commercial associations that might pose a conflict of interest in connection with the manuscript.

PII: S0165-1781(09)00003-1

doi: 10.1016/j.psychres.2008.12.009

Psychiatry Research
Volume 176, Issue 1 , Pages 30-33 , 30 March 2010

Article Tools